In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
All content for The Analytical Wavelength is the property of ACD/Labs and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
The Digital Revolution of MilliporeSigma’s Reference Materials
The Analytical Wavelength
27 minutes
1 year ago
The Digital Revolution of MilliporeSigma’s Reference Materials
MilliporeSigma’s new online digital reference platform, Chemistwin® is a trail blazing digital tool to accelerate workflows in the analytical laboratory. In this episode, ChemisTwin® Project Lead Coralie Leonard and R&D Scientist Albert Farre Perez join hosts Sarah and Bally to dive deeper into the driving factors of MilliporeSigma’s reference material business transformation process. They also give us a glimpse into the first version of the platform, and how it will pr...
The Analytical Wavelength
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
